Medicalgorithmics Begins VCAST Technology Certification in the European Union Market
Medicalgorithmics, a cardiac medtech listed on the sWIG80 index, has achieved another milestone by initiating the CE certification process for its VCAST technology, designed for non-invasive diagnosis of coronary artery disease on coronary CT scans. The AI-based VCAST technology is being developed by Kardiolytics Inc., a subsidiary of Medicalgorithmics.